Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buffered Lidocaine for Pain Reduction During Prostate Biopsy
NCT06661902Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine in prostate cancer (PCa), sponsored by University of Washington. Started Jan 2025; status: completed.
02
Drugs
lidocaine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06661902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06661902.